Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, …

2024 ESMO Annual Meeting Insights Hub

V. Kaklamani

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

Whole-Body MRI: Past, Present, and Future

Houston Methodist

N. Gupta

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Early Stage BC Clinical Overview: Grading, Staging, and Treatment Op…

University of Colorado Cancer Center

V. Borges

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

How the Experts Treat: Updates on TNBC Management

Integrity CE

S. Gandhi, S. Graff, S. Dent

Updates in the Treatment and Management of Prostate Cancer

Integrity CE

S. Kadambi, B. Guercio, M. Galsky

Cryoablation - The Big Picture

Houston Methodist

D. Abdollahian

Breast Cancer Oligometastases and Beyond

Keck School of Medicine of USC

S. Chmura

Review of mCRPC Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Dana-Farber Cancer Institute

J. Berchuck, A. Choudhury

Treatment Intensification in Advanced Prostate Cancer

Judd Moul

Year in Review: Therapeutic Advances in Prostate Cancer

OncoAlert

N. Agarwal

ESMO 2024 Summary: Bladder and RCC Highlights

2024 ESMO Annual Meeting Insights Hub

K. Tawagi, N. Reizine